Filorexant

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameFilorexant
Drug Alias Namefilorexantum非洛雷生非罗雷生MK-6096
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 1 antagonistsOrexin receptor type 2 antagonists
TargetsOrexin receptor type 1Orexin receptor type 2
Therapy Area/IndicationsDepressive Disorder, MajorHeadacheSleep Initiation and Maintenance Disorders +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorHeadacheSleep Initiation and Maintenance Disorders +[5] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG